Adam C. Ehrlich, MD, MPH, Assistant Professor of Medicine at the Lewis Katz School of Medicine at Temple University (LKSOM) and Co-Medical Director of the Inflammatory Bowel Disease Program at LKSOM, commented on a case study regarding the drug golimumab and its presence in the circulation of a fetus whose mother has ulcerative colitis. Dr. Ehrlich, who was not part of the study, shared his thoughts with Reuters Health, and MD Alert picked up that coverage.
Important announcement concerning Temple Health and Keystone First. Our provider agreement with Keystone First is scheduled to end on July 31st. Click the link below to learn about your options for continuing care at Temple Health.
Learn More
800-TEMPLE-MED
Schedule Appointment
SEARCH TEMPLE HEALTH